IP Library Granted Patent US 7,405,044
Granted Patent B2
US 7,405,044 · App. 11/245,444 · Granted Jul 29, 2008

Multiplex PCR for simultaneous quantitation of human nuclear, mitochondrial, and male Y-chromosome DNA

Assignees: Reliagene Technologies Inc.; Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,405,044
App. No.
11/245,444
Granted
Jul 29, 2008
Kind
B2
Abstract

A comprehensive set of human specific, target specific, multiplex PCR assays for DNA quantitation is provided. Our duplex qPCR for nDNA/mtDNA had a linear quantitation range of 100 ng to 1 pg, and our triplex qPCR assay for nDNA/mtDNA/male Y DNA had a linear range of 100 ng to 0.1 ng. Human-specificity was demonstrated by the accurate detection of 0.05% and 5% human DNA, respectively, from a complex source of starting templates. Target-specificity was confirmed by the lack of cross-amplification among targets. A high throughput alternative for human gender determination was also developed by multiplexing the male Y primer/probe set with an X chromosome based system. Background cross-amplification with DNA templates derived from fourteen other species was negligible aside from the male Y assay which produced spurious amplifications from other non-human primate templates. Mainstream application of these assays will undoubtedly benefit forensic genomics.

Claims (152)

1. A process for simultaneous quantitation of a human mitochondrial DNA and at least one of human nuclear DNA and human Y chromosome DNA in a sample, said process comprising the steps of:

performing multiplex polymerase chain reaction for simultaneously amplifying a region of the human mitochondrial DNA containing a human/chimp mismatch and a mitochondrial DNA/nuclear DNA mismatch by using a primer pair specific to human mitochondrial DNA, the region of the human mitochondrial DNA being not the hypervariable region, and at least one region of the human nuclear DNA containing a duplicated region of the Yb lineage of Alu subfamilies and an AluYb8 diagnostic base by using a primer pair specific to human nuclear DNA, and a region of the human Y chromosome DNA containing a 90 base pair sequence which is deleted on the human X-chromosome in an X-Y chromosome homologous region by using a primer pair specific to the human Y chromosome DNA in order to obtain an amplified products; and

quantitating the human mitochondrial DNA, and at least one of the human nuclear DNA and the human Y chromosome DNA by comparing the amplified products with a reference standard.

2. The process of claim 1 , wherein said at least one region includes both the human nuclear DNA and the human Y chromosome DNA.

3. The process of claim 1 , wherein said at least one region is the human nuclear DNA.

4. The process of claim 2 , wherein the primer pair amplifying the region of the human nuclear DNA comprises the following sequences:

5′ CTTGCAGTGAGCCGAGATT 3′;

(SEQ ID NO:13)

and

5′ GAGACGGAGTCTCGCTCTGTC 3′.

(SEQ ID NO:14)

5. The process of claim 2 , wherein the primer pair amplifying the region of the human Y chromosome DNA comprises the following sequences:

5′ CACCTACTGTGCCAGACAATGTG 3′;

(SEQ ID NO:16)

and

5′ CCCATGCCATGTTTGTCATACT 3′.

(SEQ ID NO:17)

6. The process of claim 3 , wherein the primer pair amplifying the region of the human mitochondrial DNA comprises the following sequences:

5′ AATATTAAACACAAACTACCACCTACCT 3′;

(SEQ ID NO:10)

and

5′ TGGTTCTCAGGGTTTGTTATAA 3′.

(SEQ ID NO:11)

7. The process of claim 1 , wherein the quantitation step comprises detecting the amplified products by using a quantitative PCR (qPCR) system.

8. The process of claim 1 , wherein the quantitation step further compnses using a nucleotide probe for the quantitation of the human nuclear DNA, the nucleotide probe containing the following sequence:

5′ ACTGCAGTCCGCAGTCCGGCCT 3′.

(SEQ ID NO:15)

9. The process of claim 1 , wherein the quantitation step comprises using a nucleotide probe for the quantitation of the human nuclear DNA, the nucleotide probe containing the following sequence:

5′VIC ACTGCAGTCCGCAGTCCGGCCT3′ MGBNFQ

(5′VIC-SEQ ID NO:15-3′MGBNFQ).

10. The process of claim 2 , wherein the quantitation step comprises using a nucleotide probe for the quantitation of the human Y chromosome DNA, the nucleotide probe containing the following sequence:

5′ TAGGCTCTAGGAATACAAAA 3′.

(SEQ ID NO:18)

11. The process of claim 2 , wherein the quantitation step comprises using a nucleotide probe for the quantitation of the human Y chromosome DNA, the nucleotide probe containing the following sequence:

5′ NED TAGGCTCTAGGAATACAAAA 3′ MGBNFQ (5′ NED-SEQ

ID NO:18-3′ MGBNFQ).

12. The process of claim 3 , wherein the quantitation step comprises using a nucleotide probe for the quantitation of the human mitochondrial DNA, the nucleotide probe containing the following sequence:

5′ CCTCACCAAAGCCCATA 3′.

(SEQ ID NO:12)

13. The process of claim 3 , wherein the quantitation step comprises using a nucleotide probe for the quantitation of the human mitochondrial DNA, the nucleotide probe containing the following sequence:

5′ FAM CCTCACCAAAGCCCATA 3′MGBNFQ

(5′FAM-SEQ ID NO:12-3′MGBNFQ).

14. A process for simultaneous quantitation of human nuclear DNA, human mitochondrial DNA and human Y chromosome DNA in a sample, said process comprising the steps of:

performing multiplex polymerase chain reaction to simultaneously amplify a region of the human nuclear DNA containing a human nuclear specific sequence by using a first primer pair specific to the human nuclear specific sequence, a region of the human mitochondrial DNA containing a human mitochondria specific sequence by using a second primer pair specific to the human mitochondria specific sequence, and a region of the human Y chromosome DNA containing a human Y chromosome specific sequence by using a third primer pair specific to the human Y chromosome specific sequence, the amplified region of the human nuclear DNA containing a duplicated region of the Yb lineage of Alu subfamilies and an AluYb8 diagnostic base at the 3′ end of a forward primer of the first primer pair, the amplified region of the human mitochondrial DNA containing a human/chimp mismatch and a mitochondrial DNA/nuclear DNA mismatch, the region of the human mitochondrial DNA being not the hypervariable region, the amplified region of the human Y chromosome DNA containing a 90-bp sequence which is deleted on the X chromosome in an X-Y homologous region;

measuring the amplified products from the human nuclear DNA, the human mitochondrial DNA and the human Y chromosome DNA by using a first probe for the human nuclear DNA, a second probe for the human mitochondrial DNA, and a third probe for the human Y chromosome DNA, respectively; and

quantitating the human nuclear DNA, the human mitochondrial DNA and the human Y chromosome DNA by comparing the amplified products with a reference standard.

15. The process of claim 14 , wherein the first primer pair amplifying the human nuclear DNA comprises the following sequences:

5′ CTTGCAGTGAGCCGAGATT 3′;

(SEQ ID NO:13)

and

5′ GAGACGGAGTCTCGCTCTGTC 3′.

(SEQ ID NO:14)

16. The process of claim 14 , wherein the first probe for the human nuclear DNA comprises the following sequence:

5′ ACTGCAGTCCGCAGTCCGGCCT 3′.

(SEQ ID NO:15)

17. The process of claim 14 , wherein the first probe for the human nuclear DNA comprises the following sequence:

5′VIC ACTGCAGTCCGCAGTCCGGCCT3′ MGBNFQ

(5′VIC-SEQ ID NO:15-3′MGBNFQ).

18. The process of claim 14 , wherein the second primer pair amplifying the human mitochondrial DNA comprises the following sequences:

5′ AATATTAAACACAAACTACCACCTACCT 3′;

(SEQ ID NO:10)

and

5′ TGGTTCTCAGGGTTTGTTATAA 3′.

(SEQ ID NO:11)

19. The process of claim 14 , wherein the second probe for the human mitochondrial DNA comprises the following sequence:

5′ CCTCACCAAAGCCCATA 3′.

(SEQ ID NO:12)

20. The process of claim 14 , wherein the second probe for the human mitochondrial DNA comprises the following sequence:

5′ FAM CCTCACCAAAGCCCATA 3′MGBNFQ

(5′ FAM-SEQ ID NO:12-3′MGBNFQ.

21. The process of claim 14 , wherein the third primer pair amplifying the human Y chromosome DNA comprises the following sequences:

5′ CACCTACTGTGCCAGACAATGTG 3′;

(SEQ ID NO:16)

and

5′ CCCATGCCATGTTTGTCATACT 3′.

(SEQ ID NO:17)

22. The process of claim 14 , wherein the third probe for the human Y chromosome DNA comprises the following sequence:

5′ TAGGCTCTAGGAATACAAAA 3′.

(SEQ ID NO:18)

23. The process of claim 14 , wherein the third probe for the human Y chromosome DNA comprises the following sequence:

5′ NED TAGGCTCTAGGAATACAAAA 3′ MGBNFQ (5′ NED-SEQ

ID NO:18 3′ MGBNFQ).

24. A process for simultaneously quantitating human X and Y chromosome DNA in a sample, said process comprising the steps of:

performing duplex polymerase chain reaction to amplify a region in SEQ ID NO: 9 of human Y chromosome DNA containing a 90 base pair sequence which starts from position 85 on SEQ ID NO.9 and which is deleted on SEQ ID NO: 8 of the human X-chromosome in an X-Y chromosome homologous region by using a third primer pair specific to the human Y chromosome DNA and to amplify a region in SEQ ID NO: 8 of the human X chromosome DNA in the X-Y chromosome homologous region by using a fourth primer pair; and

quantitating the human Y chromosome DNA and the human X chromosome DNA by comparing the amplified products with a reference standard.

25. The process of claim 24 , wherein the third primer pair amplifying the human Y chromosome comprises the following sequences:

5′ CACCTACTGTGCCAGACAATGTG 3′;

(SEQ ID NO:16)

and

5′ CCCATGCCATGTTTGTCATACT 3′.

(SEQ ID NO:17)

26. The process of claim 24 , wherein the quantitation step comprises using a nucleotide probe for the quantitation of the human Y chromosome DNA, the nucleotide probe containing the following sequence:

5′ TAGGCTCTAGGAATACAAAA 3′.

(SEQ ID NO:18)

27. The process of claim 24 , wherein the quantitation step comprises using a nucleotide probe for the quantitation of the human Y chromosome DNA, the nucleotide probe containing the following sequence:

5′ NED TAGGCTCTAGGAATACAAAA 3′ MGBNFQ

(5′ NED-SEQ ID NO:18-3′MGBNFQ).

28. The process of claim 24 , wherein the fourth primer pair amplifying the human X chromosome comprises the following sequences:

5′ CCACGAACTTTAATTAGTCACCTACTGT 3′;

(SEQ ID NO:19)

and

5′ ATTCCTCTCTCCATTATGTTCAATTACA 3′.

(SEQ ID NO:20)

29. The process of claim 24 , wherein the quantitation step comprises using a nucleotide probe for the quantitation of the human X chromosome DNA, the nucleotide probe containing the following sequence:

5′ CAGACAATGTGATAAATG 3′.

(SEQ ID NO:21)

30. The process of claim 24 , wherein the quantitation step comprises using a nucleotide probe for the quantitation of the human X chromosome DNA, the nucleotide probe containing the following sequence:

5′ VIC CAGACAATGTGATAAATG 3′ MGBNFQ (5′ VIC-SEQ ID

NO:21-3′ MGBNFQ).

31. The process of claim 1 , wherein said at least one region is the human Y chromosome DNA.

32. The process of claim 31 , wherein the primer pair amplifying the region of the human Y chromosome DNA comprises the following sequences:

5′ CACCTACTGTGCCAGACAATGTG 3′;

(SEQ ID NO:16)

and

5′ CCCATGCCATGTTTGTCATACT 3′.

(SEQ ID NO:17)

33. The process of claim 32 , wherein the primer pair amplifying the region of the human mitochondrial DNA comprises the following sequences:

5′ AATATTAAACACAAACTACCACCTACCT 3′;

(SEQ ID NO:10)

and

5′ TGGTTCTCAGGGTTTGTTATAA 3′.

(SEQ ID NO:11)

34. The process of claim 31 , wherein the primer pair amplifying the region of the human mitochondrial DNA comprises the following sequences:

5′AATATTAAACACAAACTACCACCTACCT 3′(SEQ ID NO: 10); and

5′TGGTTCTCAGGGTTTGTTATAA 3′(SEQ ID NO: 11).

35. The process of claim 3 , wherein the primer pair amplifying the region of the human nuclear DNA comprises the following sequences:

5′ CTTGCAGTGAGCCGAGATT 3′;

(SEQ ID NO:13)

and

5′ GAGACGGAGTCTCGCTCTGTC 3′.

(SEQ ID NO:14)

36. The process of claim 35 , wherein the primer pair amplifying the region of the human mitochondrial DNA comprises the following sequences:

5′ AATATTAAACACAAACTACCACCTACCT 3′;

(SEQ ID NO:10)

and

5′ TGGTTCTCAGGGTTTGTTATAA 3′.

(SEQ ID NO:11)

37. The process of claim 2 , wherein the primer pair amplifying the region of the human mitochondrial DNA comprises the following sequences:

5′AATATTAAACACAAACTACCACCTACCT 3′(SEQ ID NO: 10); and

5′TGGTTCTCAGGGTTTGTTATAA 3′(SEQ ID NO: 11);

the primer pair amplifying the region of the human nuclear DNA comprises the following sequences:

5′ CTTGCAGTGAGCCGAGATT 3′;

(SEQ ID NO:13)

and

5′ GAGACGGAGTCTCGCTCTGTC 3′.

(SEQ ID NO:14)

the primer pair amplifying the region of the human Y chromosome DNA comprises the following sequences:

5′ CACCTACTGTGCCAGACAATGTG 3′;

(SEQ ID NO:16)

and

5′ CCCATGCCATGTTTGTCATACT 3′.

(SEQ ID NO:17)

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 22, 2008
From: ORCHID CELLMARK INC.
To: LIFE GENETICS LAB, LLC, A BODY CORPORATE CHARTERED IN AND EXISTING UNDER THE LAWS OF THE STATE OF LOUISIANA, THAT MAINTAINS ITS PRINCIPAL OFFICES AT:
Reel/Frame 021570/0816 →
CONFIRMATORY LICENSE Recorded Apr 12, 2007
From: LOUISANA STATE UNIVERSITY A&M COL BATON ROUGE
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 019153/0565 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 17, 2006
From: SHEWALE, JAIPRAKASH G.; SINHA, SUDHIR K.
To: RELIAGENE TECHNOLOGIES INC., A CORPORATION ORGANIZED UNDER THE LAWS OF THE STATE OF LOUISIANA
Reel/Frame 017474/0901 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2005
From: WALKER, JERILYN A.; HEDGES, DALE J.; BATZER, MARK A.
To: BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE
Reel/Frame 017157/0222 →
Continuity (2)
Provisional Application 6061685200 · Oct 8, 2004
Related Publication 20060099620A1 · May 11, 2006